BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America
Share:
Email this page Share this on LinkedIn Share this on Twitter

BioPharm America™ 2014 Press Releases

October 2, 2014Record number of licensing opportunities presented at BioPharm America™ 2014 International Life Science Partnering Event in Boston The seventh annual BioPharm America international life science partnering conference wrapped up last week, September 22–24, at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event was attended by close to 900 high-level delegates representing 511 companies from 38 countries who engaged in 2,343 one-to-one partnering meetings with 787 lice...  more ►

September 22, 2014FierceBiotech's 2014 "Fierce 15" Announced Today at BioPharm America™ 2014International Life Science Partnering Event in Boston
The seventh annual BioPharm America international life science partnering conference kicked off today in Boston with the live announcement of the biotech's most daring characters in biopharma, the "Fierce 15," by John Carroll, Editor-in-Chief of FierceBiotech. "It's always a lot of fun to look over a new group of Fierce 15 companies," said John Carroll, Editor-in-Chief, of ...  more ►

September 8, 2014BioPharm America™ 2014 leads off with Fierce 15 Announcement and Keynote Address featuring Chief Scientific Officer from Sanofi The seventh annual BioPharm America international life science partnering conference will kick off in a less than two weeks, September 22–24, at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The highly reputable life science partnering event will draw biotech and pharma executives from around the world to identify and enter into strategic r...  more ►

August 19, 2014Renewed investor appetite in biotech innovation means strong attendance expected at BioPharm America™ 2014 The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event is a big draw for pharma and investors who want to access innovative new potential therapies and cures brought by international biotech companies. "Today is a great time...  more ►

May 20, 2014Collaborative models and IPO window are hot topics at BioPharm America™ 2014 program The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event brings together industry thought leaders and high level executives in the biopharma dealmaking arena to collaborate on and discuss relevant trends and topics. Several i...  more ►

April 15, 2014BioPharm America™ 2014 returns to Boston's Copley Place and a celebration of the FierceBiotech Fierce 15 The seventh annual BioPharm America international life science partnering conference will be held at Boston Marriott Copley Place in the center of Boston's historic Back Bay. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the September 22–24 event will bring the global life science industry to Boston to facilitate strategic ...  more ►


partnering360® Blog

October 24, 2014 Insight into Antigen Express’ immunotherapy Antigen Express is a company who uses their technology to promote immunotherapy to fight many cancers and develop vaccines so that the human body can defend itself. According to a recent article at Insight, their patented peptides are critical in developing immune responses. How does this therapy... more ►

October 23, 2014 Why did only a few European biotechs make it through the IPO window? Guest post from Steve Dickman, CEO, CBT Advisors. Originally posted to Boston Biotech Watch. If the recent falloff in biotech IPOs continues, then many European biotechs would seem to have missed the longest, widest IPO window in the history of the industry. Why did a few European biotechs manage... more ►

October 21, 2014 News from around BIO-Europe® With BIO-Europe just weeks away, many companies are have moved various products along the pipeline and many are seeing success in developing and moving drugs through pipelines: - Apricus Biosciences recently announced that Notice of Allowance for they have received U.S. Patent Application Serial... more ►

October 17, 2014 MediSapiens and Mediconomics look to collaboration for growth To gear up for BIO-Europe®, our team at Insight has spoken with some of the companies coming to the event early next month to see what they’re doing and who they’re looking to meet with at the event. Experimental Therapeutics Centre (ETC), one of a few fully integrated drug discovery... more ►

October 16, 2014 Outtakes from the Stem Cell Meeting on the Mesa 2014 plenary The recent Stem Cell Meeting on the Mesa 2014 opened with a timely plenary session entitled “Cell Therapy Product Development: Maintaining Momentum in the Face of Expected Clinical Challenges.” The panel was chaired by Mark Stevenson, EVP & President, Life Science Solutions, Life... more ►



partnering360:Insight Latest headlines from partnering360:Insight

October 20, 2014 Merck Serono: FIT for partnering and playing with the home court advantage "We are interested in opportunities—spanning from promising drug candidates up to technology platforms—that will support our strategic business objectives, and strengthen our pipeline, our key franchises, and our geographic presence." more ►

October 17, 2014 Antigen Express advances immunotherapy Antigen Express is developing a novel way to boost the immune system, developing a therapeutic platform that can produce off-the-shelf, synthetic peptide vaccines for major diseases, including cancer, HIV, influenza, diabetes and, potentially, Ebola. more ►

October 17, 2014 Third Rock Ventures sees “renaissance of innovation in life sciences” A co-founder of Third Rock Ventures, Kevin Starr focuses on the development and business strategy of the portfolio companies, actively identifying and evaluating new investments. In March, 2013 the firm raised USD 516 million for its Fund III. Several new companies have since been launched and Starr said a further 14 companies will be formed, "most of which are already under consideration inside Third Rock, though we have not announced anything to the outside world yet." more ►

October 13, 2014 Accelerating drug discovery in Singapore creates global successes Building on a string of recent successes, a team from Singapore's Experimental Therapeutics Centre (ETC) arrives in Frankfurt for BIO-Europe® 2014 looking for new opportunities in early stage co-discovery projects. more ►

October 11, 2014 Customized bio-IT solutions are not just for big pharma anymore BIO-Europe® 2014 in Frankfurt will see the soft launch for a bundled product-and-service called the MediSapiens Explorer Platform that brings to small and medium-sized biotechs and pharma companies a platform for managing and accessing massive data sets, and the tools to visualize it in scientist-friendly way. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD Group, Inc.
Privacy Policy
Terms of Use
BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America